Ex Parte WILMET et al - Page 7




            Appeal No. 2002-1618                                                                              
            Application No. 09/051,746                                                                        
                   In our view, appellants have placed evidence of record which controverts any               
            such “analogy” which may have been put forth by the examiner.  Note, Paper No. 12,                
            pages 4-5, where appellants provide a detailed explanation of Advances in Fluoride                
            Chemistry, Vol. 3, p. 180-183, 200-209, previously made of record.  See also, Brief,              
            page 9.   We also agree with appellants that the examiner has not come to grips with or           
            rebutted this argument.  See, Answer, page 5.                                                     
                   In view of the above, we find the examiner has failed to present sufficient                
            evidence to support a prima facie case of obviousness.                                            
                   After evidence or argument is submitted by the applicants in response to an                
            obviousness rejection, "patentability is determined on the totality of the record, by a           
            preponderance of evidence with due consideration to persuasiveness of the argument."              
            In re Oetiker,  977 F.2d 1443, 1445,  24 USPQ2d 1443, 1444 (Fed. Cir. 1992); see In re            
            Piasecki,  745 F.2d 1468, 1471-72,  223 USPQ 785, 787 (Fed. Cir. 1984) ("All evidence             
            on the question of obviousness must be considered, both that supporting and that                  
            rebutting the prima facie case.").  On balance, we believe that the totality of the               
            evidence presented by the examiner and appellants weighs in favor of finding the                  
            claimed invention non-obvious.  The rejection is reversed.                                        








                                                      7                                                       





Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007